Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice

PTEN haploinsufficiency plays an important role in prostate cancer development in men. However, monoallelic deletion of Pten gene failed to induce high prostate intraepithelial neoplasia (PIN) until Pten+/− mice aged or fed a high-calorie diet. Because CEACAM1, a cell adhesion molecule with a potent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolism, clinical and experimental clinical and experimental, 2020-06, Vol.107, p.154215-154215, Article 154215
Hauptverfasser: Liu, Jehnan, Muturi, Harrison T., Khuder, Saja S., Helal, Raghd Abu, Ghadieh, Hilda E., Ramakrishnan, Sadeesh K., Kaw, Meenakshi K., Lester, Sumona Ghosh, Al-Khudhair, Ahmed, Conran, Philip B., Chin, Khew-Voon, Gatto-Weis, Cara, Najjar, Sonia M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 154215
container_issue
container_start_page 154215
container_title Metabolism, clinical and experimental
container_volume 107
creator Liu, Jehnan
Muturi, Harrison T.
Khuder, Saja S.
Helal, Raghd Abu
Ghadieh, Hilda E.
Ramakrishnan, Sadeesh K.
Kaw, Meenakshi K.
Lester, Sumona Ghosh
Al-Khudhair, Ahmed
Conran, Philip B.
Chin, Khew-Voon
Gatto-Weis, Cara
Najjar, Sonia M.
description PTEN haploinsufficiency plays an important role in prostate cancer development in men. However, monoallelic deletion of Pten gene failed to induce high prostate intraepithelial neoplasia (PIN) until Pten+/− mice aged or fed a high-calorie diet. Because CEACAM1, a cell adhesion molecule with a potential tumor suppression activity, is induced in Pten+/− prostates, the study aimed at examining whether the rise of CEACAM1 limited neoplastic progression in Pten+/− prostates. Pten+/− were crossbred with Cc1−/− mice harboring a null deletion of Ceacam1 gene to produce Pten+/−/Cc1−/− double mutants. Prostates from 7-month old male mice were analyzed histologically and biochemically for PIN progression. Deleting Ceacam1 in Pten+/− mice caused an early development of high-grade PIN in parallel to hyperactivation of PI3 kinase/Akt and Ras/MAP kinase pathways, with an increase in cell proliferation, epithelial-to-mesenchymal transition, angiogenesis and inflammation relative to Pten+/− and Cc1−/− individual mutants. It also caused a remarkable increase in lipogenesis in prostate despite maintaining insulin sensitivity. Concomitant Ceacam1 deletion with Pten+/− activated the IL-6/STAT3 signaling pathways to suppress Irf-8 transcription that in turn, led to a decrease in the expression level of promyelocytic leukemia gene, a well characterized tumor suppressor in prostate. Ceacam1 deletion accelerated high-grade prostate intraepithelial neoplasia in Pten haploinsufficient mice while preserving insulin sensitivity. This demonstrated that the combined loss of Ceacam1 and Pten advanced prostate cancer by increasing lipogenesis and modifying the STAT3-dependent inflammatory microenvironment of prostate. •CEACAM1-4L expression is elevated in prostates of Pten+/− mice.•Ceacam1 deletion causes progression of neoplasia in prostates of Pten+/− mice.•Ceacam1 deletion causes EMT and angiogenesis in prostates of Pten+/− mice.•Ceacam1 deletion causes lipogenesis and inflammation in prostates of Pten+/− mice.•Ceacam1 deletion activates STAT3 to limit Irf-8 and Pml transcription in Pten+/−.
doi_str_mv 10.1016/j.metabol.2020.154215
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7283002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026049520300792</els_id><sourcerecordid>2383513532</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3825-25fca337e9093f5e69edff012d164919d954563e1aa54ba8319cb627deb8aa7a3</originalsourceid><addsrcrecordid>eNqFUU1r3DAQFaUh2aT5CS069uKtPizZvjSUpU0CC8khgd7EWB4lWmxrK3kX8u8js9uQnnrSaObNm8d7hHzmbMkZ1982ywEnaEO_FEzknioFVx_Igispiloz9pEsGBO6YGWjzsh5ShvGWFXV-pScSSFYIzVbkN_rkBINjq4QLAycbmMYwoRpLtIEE1ILo8U4_58ipuTDSP1I7ycc6TNs--DHtHPOW4_jRAfokQ7e4idy4qBPeHl8L8jjr58Pq5tifXd9u_qxLqyshSqEchakrLDJgpxC3WDnHOOi47pseNM1qlRaIgdQZQu15I1ttag6bGuACuQF-X7g3e7aATubRUTozTb6AeKLCeDNv5PRP5unsDeVqGU2KBN8PRLE8GeHaTKDTxb7HkYMu2SErKXiMtuaoeoAtdmbFNG9neHMzKmYjTmmYuZUzCGVvPflvca3rb8xZMDVAYDZqb3HaNJsp8XOR7ST6YL_z4lXd3miXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2383513532</pqid></control><display><type>article</type><title>Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Liu, Jehnan ; Muturi, Harrison T. ; Khuder, Saja S. ; Helal, Raghd Abu ; Ghadieh, Hilda E. ; Ramakrishnan, Sadeesh K. ; Kaw, Meenakshi K. ; Lester, Sumona Ghosh ; Al-Khudhair, Ahmed ; Conran, Philip B. ; Chin, Khew-Voon ; Gatto-Weis, Cara ; Najjar, Sonia M.</creator><creatorcontrib>Liu, Jehnan ; Muturi, Harrison T. ; Khuder, Saja S. ; Helal, Raghd Abu ; Ghadieh, Hilda E. ; Ramakrishnan, Sadeesh K. ; Kaw, Meenakshi K. ; Lester, Sumona Ghosh ; Al-Khudhair, Ahmed ; Conran, Philip B. ; Chin, Khew-Voon ; Gatto-Weis, Cara ; Najjar, Sonia M.</creatorcontrib><description>PTEN haploinsufficiency plays an important role in prostate cancer development in men. However, monoallelic deletion of Pten gene failed to induce high prostate intraepithelial neoplasia (PIN) until Pten+/− mice aged or fed a high-calorie diet. Because CEACAM1, a cell adhesion molecule with a potential tumor suppression activity, is induced in Pten+/− prostates, the study aimed at examining whether the rise of CEACAM1 limited neoplastic progression in Pten+/− prostates. Pten+/− were crossbred with Cc1−/− mice harboring a null deletion of Ceacam1 gene to produce Pten+/−/Cc1−/− double mutants. Prostates from 7-month old male mice were analyzed histologically and biochemically for PIN progression. Deleting Ceacam1 in Pten+/− mice caused an early development of high-grade PIN in parallel to hyperactivation of PI3 kinase/Akt and Ras/MAP kinase pathways, with an increase in cell proliferation, epithelial-to-mesenchymal transition, angiogenesis and inflammation relative to Pten+/− and Cc1−/− individual mutants. It also caused a remarkable increase in lipogenesis in prostate despite maintaining insulin sensitivity. Concomitant Ceacam1 deletion with Pten+/− activated the IL-6/STAT3 signaling pathways to suppress Irf-8 transcription that in turn, led to a decrease in the expression level of promyelocytic leukemia gene, a well characterized tumor suppressor in prostate. Ceacam1 deletion accelerated high-grade prostate intraepithelial neoplasia in Pten haploinsufficient mice while preserving insulin sensitivity. This demonstrated that the combined loss of Ceacam1 and Pten advanced prostate cancer by increasing lipogenesis and modifying the STAT3-dependent inflammatory microenvironment of prostate. •CEACAM1-4L expression is elevated in prostates of Pten+/− mice.•Ceacam1 deletion causes progression of neoplasia in prostates of Pten+/− mice.•Ceacam1 deletion causes EMT and angiogenesis in prostates of Pten+/− mice.•Ceacam1 deletion causes lipogenesis and inflammation in prostates of Pten+/− mice.•Ceacam1 deletion activates STAT3 to limit Irf-8 and Pml transcription in Pten+/−.</description><identifier>ISSN: 0026-0495</identifier><identifier>ISSN: 1532-8600</identifier><identifier>EISSN: 1532-8600</identifier><identifier>DOI: 10.1016/j.metabol.2020.154215</identifier><identifier>PMID: 32209360</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Carcinoembryonic Antigen - genetics ; CEACAM1 ; Disease Progression ; Fatty acid synthase ; Haploinsufficiency ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mutation ; Neoplasia ; Normoinsulinemia ; Oncogene Protein v-akt - genetics ; Phosphatidylinositol 3-Kinases - genetics ; PML ; Prostate intraepithelial neoplasia ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - pathology ; PTEN Phosphohydrolase - genetics ; PTEN tumor suppression ; Signal Transduction - drug effects ; Signal Transduction - genetics ; STAT3 Transcription Factor - genetics</subject><ispartof>Metabolism, clinical and experimental, 2020-06, Vol.107, p.154215-154215, Article 154215</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3825-25fca337e9093f5e69edff012d164919d954563e1aa54ba8319cb627deb8aa7a3</citedby><cites>FETCH-LOGICAL-c3825-25fca337e9093f5e69edff012d164919d954563e1aa54ba8319cb627deb8aa7a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0026049520300792$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32209360$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Jehnan</creatorcontrib><creatorcontrib>Muturi, Harrison T.</creatorcontrib><creatorcontrib>Khuder, Saja S.</creatorcontrib><creatorcontrib>Helal, Raghd Abu</creatorcontrib><creatorcontrib>Ghadieh, Hilda E.</creatorcontrib><creatorcontrib>Ramakrishnan, Sadeesh K.</creatorcontrib><creatorcontrib>Kaw, Meenakshi K.</creatorcontrib><creatorcontrib>Lester, Sumona Ghosh</creatorcontrib><creatorcontrib>Al-Khudhair, Ahmed</creatorcontrib><creatorcontrib>Conran, Philip B.</creatorcontrib><creatorcontrib>Chin, Khew-Voon</creatorcontrib><creatorcontrib>Gatto-Weis, Cara</creatorcontrib><creatorcontrib>Najjar, Sonia M.</creatorcontrib><title>Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice</title><title>Metabolism, clinical and experimental</title><addtitle>Metabolism</addtitle><description>PTEN haploinsufficiency plays an important role in prostate cancer development in men. However, monoallelic deletion of Pten gene failed to induce high prostate intraepithelial neoplasia (PIN) until Pten+/− mice aged or fed a high-calorie diet. Because CEACAM1, a cell adhesion molecule with a potential tumor suppression activity, is induced in Pten+/− prostates, the study aimed at examining whether the rise of CEACAM1 limited neoplastic progression in Pten+/− prostates. Pten+/− were crossbred with Cc1−/− mice harboring a null deletion of Ceacam1 gene to produce Pten+/−/Cc1−/− double mutants. Prostates from 7-month old male mice were analyzed histologically and biochemically for PIN progression. Deleting Ceacam1 in Pten+/− mice caused an early development of high-grade PIN in parallel to hyperactivation of PI3 kinase/Akt and Ras/MAP kinase pathways, with an increase in cell proliferation, epithelial-to-mesenchymal transition, angiogenesis and inflammation relative to Pten+/− and Cc1−/− individual mutants. It also caused a remarkable increase in lipogenesis in prostate despite maintaining insulin sensitivity. Concomitant Ceacam1 deletion with Pten+/− activated the IL-6/STAT3 signaling pathways to suppress Irf-8 transcription that in turn, led to a decrease in the expression level of promyelocytic leukemia gene, a well characterized tumor suppressor in prostate. Ceacam1 deletion accelerated high-grade prostate intraepithelial neoplasia in Pten haploinsufficient mice while preserving insulin sensitivity. This demonstrated that the combined loss of Ceacam1 and Pten advanced prostate cancer by increasing lipogenesis and modifying the STAT3-dependent inflammatory microenvironment of prostate. •CEACAM1-4L expression is elevated in prostates of Pten+/− mice.•Ceacam1 deletion causes progression of neoplasia in prostates of Pten+/− mice.•Ceacam1 deletion causes EMT and angiogenesis in prostates of Pten+/− mice.•Ceacam1 deletion causes lipogenesis and inflammation in prostates of Pten+/− mice.•Ceacam1 deletion activates STAT3 to limit Irf-8 and Pml transcription in Pten+/−.</description><subject>Animals</subject><subject>Carcinoembryonic Antigen - genetics</subject><subject>CEACAM1</subject><subject>Disease Progression</subject><subject>Fatty acid synthase</subject><subject>Haploinsufficiency</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mutation</subject><subject>Neoplasia</subject><subject>Normoinsulinemia</subject><subject>Oncogene Protein v-akt - genetics</subject><subject>Phosphatidylinositol 3-Kinases - genetics</subject><subject>PML</subject><subject>Prostate intraepithelial neoplasia</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - pathology</subject><subject>PTEN Phosphohydrolase - genetics</subject><subject>PTEN tumor suppression</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - genetics</subject><subject>STAT3 Transcription Factor - genetics</subject><issn>0026-0495</issn><issn>1532-8600</issn><issn>1532-8600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUU1r3DAQFaUh2aT5CS069uKtPizZvjSUpU0CC8khgd7EWB4lWmxrK3kX8u8js9uQnnrSaObNm8d7hHzmbMkZ1982ywEnaEO_FEzknioFVx_Igispiloz9pEsGBO6YGWjzsh5ShvGWFXV-pScSSFYIzVbkN_rkBINjq4QLAycbmMYwoRpLtIEE1ILo8U4_58ipuTDSP1I7ycc6TNs--DHtHPOW4_jRAfokQ7e4idy4qBPeHl8L8jjr58Pq5tifXd9u_qxLqyshSqEchakrLDJgpxC3WDnHOOi47pseNM1qlRaIgdQZQu15I1ttag6bGuACuQF-X7g3e7aATubRUTozTb6AeKLCeDNv5PRP5unsDeVqGU2KBN8PRLE8GeHaTKDTxb7HkYMu2SErKXiMtuaoeoAtdmbFNG9neHMzKmYjTmmYuZUzCGVvPflvca3rb8xZMDVAYDZqb3HaNJsp8XOR7ST6YL_z4lXd3miXg</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Liu, Jehnan</creator><creator>Muturi, Harrison T.</creator><creator>Khuder, Saja S.</creator><creator>Helal, Raghd Abu</creator><creator>Ghadieh, Hilda E.</creator><creator>Ramakrishnan, Sadeesh K.</creator><creator>Kaw, Meenakshi K.</creator><creator>Lester, Sumona Ghosh</creator><creator>Al-Khudhair, Ahmed</creator><creator>Conran, Philip B.</creator><creator>Chin, Khew-Voon</creator><creator>Gatto-Weis, Cara</creator><creator>Najjar, Sonia M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200601</creationdate><title>Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice</title><author>Liu, Jehnan ; Muturi, Harrison T. ; Khuder, Saja S. ; Helal, Raghd Abu ; Ghadieh, Hilda E. ; Ramakrishnan, Sadeesh K. ; Kaw, Meenakshi K. ; Lester, Sumona Ghosh ; Al-Khudhair, Ahmed ; Conran, Philip B. ; Chin, Khew-Voon ; Gatto-Weis, Cara ; Najjar, Sonia M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3825-25fca337e9093f5e69edff012d164919d954563e1aa54ba8319cb627deb8aa7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Carcinoembryonic Antigen - genetics</topic><topic>CEACAM1</topic><topic>Disease Progression</topic><topic>Fatty acid synthase</topic><topic>Haploinsufficiency</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mutation</topic><topic>Neoplasia</topic><topic>Normoinsulinemia</topic><topic>Oncogene Protein v-akt - genetics</topic><topic>Phosphatidylinositol 3-Kinases - genetics</topic><topic>PML</topic><topic>Prostate intraepithelial neoplasia</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - pathology</topic><topic>PTEN Phosphohydrolase - genetics</topic><topic>PTEN tumor suppression</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - genetics</topic><topic>STAT3 Transcription Factor - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Jehnan</creatorcontrib><creatorcontrib>Muturi, Harrison T.</creatorcontrib><creatorcontrib>Khuder, Saja S.</creatorcontrib><creatorcontrib>Helal, Raghd Abu</creatorcontrib><creatorcontrib>Ghadieh, Hilda E.</creatorcontrib><creatorcontrib>Ramakrishnan, Sadeesh K.</creatorcontrib><creatorcontrib>Kaw, Meenakshi K.</creatorcontrib><creatorcontrib>Lester, Sumona Ghosh</creatorcontrib><creatorcontrib>Al-Khudhair, Ahmed</creatorcontrib><creatorcontrib>Conran, Philip B.</creatorcontrib><creatorcontrib>Chin, Khew-Voon</creatorcontrib><creatorcontrib>Gatto-Weis, Cara</creatorcontrib><creatorcontrib>Najjar, Sonia M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Metabolism, clinical and experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Jehnan</au><au>Muturi, Harrison T.</au><au>Khuder, Saja S.</au><au>Helal, Raghd Abu</au><au>Ghadieh, Hilda E.</au><au>Ramakrishnan, Sadeesh K.</au><au>Kaw, Meenakshi K.</au><au>Lester, Sumona Ghosh</au><au>Al-Khudhair, Ahmed</au><au>Conran, Philip B.</au><au>Chin, Khew-Voon</au><au>Gatto-Weis, Cara</au><au>Najjar, Sonia M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice</atitle><jtitle>Metabolism, clinical and experimental</jtitle><addtitle>Metabolism</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>107</volume><spage>154215</spage><epage>154215</epage><pages>154215-154215</pages><artnum>154215</artnum><issn>0026-0495</issn><issn>1532-8600</issn><eissn>1532-8600</eissn><abstract>PTEN haploinsufficiency plays an important role in prostate cancer development in men. However, monoallelic deletion of Pten gene failed to induce high prostate intraepithelial neoplasia (PIN) until Pten+/− mice aged or fed a high-calorie diet. Because CEACAM1, a cell adhesion molecule with a potential tumor suppression activity, is induced in Pten+/− prostates, the study aimed at examining whether the rise of CEACAM1 limited neoplastic progression in Pten+/− prostates. Pten+/− were crossbred with Cc1−/− mice harboring a null deletion of Ceacam1 gene to produce Pten+/−/Cc1−/− double mutants. Prostates from 7-month old male mice were analyzed histologically and biochemically for PIN progression. Deleting Ceacam1 in Pten+/− mice caused an early development of high-grade PIN in parallel to hyperactivation of PI3 kinase/Akt and Ras/MAP kinase pathways, with an increase in cell proliferation, epithelial-to-mesenchymal transition, angiogenesis and inflammation relative to Pten+/− and Cc1−/− individual mutants. It also caused a remarkable increase in lipogenesis in prostate despite maintaining insulin sensitivity. Concomitant Ceacam1 deletion with Pten+/− activated the IL-6/STAT3 signaling pathways to suppress Irf-8 transcription that in turn, led to a decrease in the expression level of promyelocytic leukemia gene, a well characterized tumor suppressor in prostate. Ceacam1 deletion accelerated high-grade prostate intraepithelial neoplasia in Pten haploinsufficient mice while preserving insulin sensitivity. This demonstrated that the combined loss of Ceacam1 and Pten advanced prostate cancer by increasing lipogenesis and modifying the STAT3-dependent inflammatory microenvironment of prostate. •CEACAM1-4L expression is elevated in prostates of Pten+/− mice.•Ceacam1 deletion causes progression of neoplasia in prostates of Pten+/− mice.•Ceacam1 deletion causes EMT and angiogenesis in prostates of Pten+/− mice.•Ceacam1 deletion causes lipogenesis and inflammation in prostates of Pten+/− mice.•Ceacam1 deletion activates STAT3 to limit Irf-8 and Pml transcription in Pten+/−.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32209360</pmid><doi>10.1016/j.metabol.2020.154215</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0026-0495
ispartof Metabolism, clinical and experimental, 2020-06, Vol.107, p.154215-154215, Article 154215
issn 0026-0495
1532-8600
1532-8600
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7283002
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Carcinoembryonic Antigen - genetics
CEACAM1
Disease Progression
Fatty acid synthase
Haploinsufficiency
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Mutation
Neoplasia
Normoinsulinemia
Oncogene Protein v-akt - genetics
Phosphatidylinositol 3-Kinases - genetics
PML
Prostate intraepithelial neoplasia
Prostatic Neoplasms - genetics
Prostatic Neoplasms - pathology
PTEN Phosphohydrolase - genetics
PTEN tumor suppression
Signal Transduction - drug effects
Signal Transduction - genetics
STAT3 Transcription Factor - genetics
title Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T02%3A55%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Loss%20of%20Ceacam1%20promotes%20prostate%20cancer%20progression%20in%20Pten%20haploinsufficient%20male%20mice&rft.jtitle=Metabolism,%20clinical%20and%20experimental&rft.au=Liu,%20Jehnan&rft.date=2020-06-01&rft.volume=107&rft.spage=154215&rft.epage=154215&rft.pages=154215-154215&rft.artnum=154215&rft.issn=0026-0495&rft.eissn=1532-8600&rft_id=info:doi/10.1016/j.metabol.2020.154215&rft_dat=%3Cproquest_pubme%3E2383513532%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2383513532&rft_id=info:pmid/32209360&rft_els_id=S0026049520300792&rfr_iscdi=true